Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Articles
  3. antigen target
Show results for

Refine by
Date

  • This Year
  • Older

Antigen Target Articles & Analysis

35 articles found

Single-Domain Antibody Production: A Comprehensive Overview

Single-Domain Antibody Production: A Comprehensive Overview

Advantages of Single-Domain Antibodies Size and Specificity: Their small size enables them to penetrate tissues more effectively and reach targets that larger antibodies cannot. This characteristic enhances their specificity and affinity for antigens. ...

ByCreative Biogene


Bokes AB Antibody Sequencing

Bokes AB Antibody Sequencing

In biomedical research, antibodies are a powerful tool used in the detection and quantification of target antigens. However, a comprehensive understanding of the antibody requires knowledge of its amino acid sequence, which can be achieved through antibody sequencing.Antibody sequencing is a nucleic acid sequencing process that determines the nucleotide sequence ...

ByMtoZ Biolabs


   Harnessing the Power of the Immune System: The Rise of Cancer Vaccines in Oncology

Harnessing the Power of the Immune System: The Rise of Cancer Vaccines in Oncology

This antigen-antibody binding is a critical mechanism used by our immune system to target and eliminate threats effectively. ...

ByAlfa Cytology


Analysis of ADC Drug Biological Activity

Analysis of ADC Drug Biological Activity

Compared with traditional cytotoxins, ADCs have the advantages of strong targeting, less toxic side effects, etc. They can accurately target tumor cells, reduce side effects, and improve the therapeutic effect.ADC drugs are mainly composed of monoclonal antibodies, linkers, and small molecule cytotoxins. ...

ByMtoZ Biolabs


Peptide Antigen: the Successful Strategy of "Less is More"

Peptide Antigen: the Successful Strategy of "Less is More"

The Unique Value and Challenges of Peptide Antigens in Antibody DiscoveryChoosing the right antigen is crucial in antibody discovery. ...

ByMtoZ Biolabs


Selection of Antibodies: 10 Steps

Selection of Antibodies: 10 Steps

You can use GeneNames to find the official name of the target protein, and then use GeneCards to identify aliases to expand the possible search range, because antibody suppliers may use different aliases to name the same protein.Determine Other Information of the Target ProteinDetermine the isotypes, functional domains, processed forms, structural domains with ...

ByMtoZ Biolabs


AI and Multiplex Cloning Redefine Aantibody Discovery

AI and Multiplex Cloning Redefine Aantibody Discovery

Therefore, the application of computer simulation is expected to reduce reliance on expensive and time-consuming trial-and-error experiments, promoting efficient progress in antibody research and development.Main Challenges in Antibody Discovery1. Difficult to Target Antigens and Novel Drug TargetsDifficult-to-target antigens and ...

ByMtoZ Biolabs


Q&A: The evolving role of antibody-drug conjugates in oncology

Q&A: The evolving role of antibody-drug conjugates in oncology

Kate Sasser from Tempus led a discussion on the potential of antibody-drug conjugates (ADCs), their challenges in targeting tumor antigens, and the future of cancer treatment with Dr. Daniel Johnson, Dr. ...

ByTempus


Antibody Drug Activity Testing

Antibody Drug Activity Testing

To ensure the effectiveness and safety of these antibody drugs, it is necessary to perform activity testing.Definition of Antibody ActivityThe activity of an antibody drug usually refers to its ability to bind to the target antigen and how it affects the target in a biological function, such as neutralizing viruses, killing tumor cells, or ...

ByMtoZ Biolabs


Development of Nanobody-Based Drug Delivery Systems

Development of Nanobody-Based Drug Delivery Systems

One of the first applications of nanobodies in drug delivery was the development of targeted drug delivery systems. Nanobodies can be engineered to specifically target tissues or cells of interest by conjugating them to therapeutic agents. This targeting ability minimizes off-target effects and increases the efficacy of the drug. ...

ByBOC Sciences


From Lab to Market: The Journey of Monoclonal Antibody Development   

From Lab to Market: The Journey of Monoclonal Antibody Development  

These therapeutic antibodies aim to specifically target antigens on the surface of cells and bind to them, leading to acidic reactions that result in the destruction of target cells. ...

ByAlfa Cytology


Drug Conjugates: Latest Research Progress

Drug Conjugates: Latest Research Progress

BOC Sciences offers a variety of linkers, including cleavable linkers, non-cleavable linkers, and pH-sensitive linkers, to accommodate different drug payloads and target antigens. These linkers are designed to be stable in circulation but release cytotoxicity upon internalization by target cancer cells, ensuring maximum therapeutic efficacy while ...

ByBOC Sciences


CD Biosciences Launches Substrate-Chromogens for Immunohistochemistry

CD Biosciences Launches Substrate-Chromogens for Immunohistochemistry

Immunohistochemistry is the study of the localization, characterization, and relative quantification of peptides and proteins in tissue cells using the antigen-antibody reaction, in which an antigen specifically binds to an antibody and a chemical reaction results in the visualization of dyes such as fluorescein and other chromogens, as well as enzymes, metal ...

ByCD BioSciences


Characteristics and Applications of Luminex Multiplex Technology

Characteristics and Applications of Luminex Multiplex Technology

Each color microsphere is covalently cross-linked with a probe, antigen or antibody targeting a specific assay. The different microspheres bind proteins (antibodies or antigens for immunoassays) against different substances to be detected. The detection antibody is labeled with biotin and stained with a highly sensitive fluorescent dye. Coded ...

ByCreative Proteomics


ADC Cleavable Linker : Classification and Mechanism of Action

ADC Cleavable Linker : Classification and Mechanism of Action

In order to ensure the selectivity and efficacy of ADC, linker should strive to achieve three key features :(1) High cycle stability: Payload will not be released before it reaches the target, thereby minimizing the off-target effects.(2) High water solubility: it is helpful for coupling and avoids the formation of inactive ADC aggregates.(3) Efficient release: ...

ByBOC Sciences


How to Design a Good ADC Drug

How to Design a Good ADC Drug

Antibody Backbone: The Starting Point for ADC Design l Selection of antigen specificity Since the mechanism of ADCs begins with the binding of target cells, the antibody should have high specificity for the target antigen. ...

ByBOC Sciences


ADC Drugs For HER2 Positive Breast Cancer

ADC Drugs For HER2 Positive Breast Cancer

They combine the high specificity of monoclonal antibody drugs with the high activity of small molecule cytotoxic drugs, which can improve the targeting of antitumor drugs and reduce the probability of toxic and side effects. An antibody drug conjugate (ADC) consists of three core elements: an antibody that targets a target ...

ByHunan Huateng Pharmaceutical Co. Ltd.


Optimization of Three Elements of ADC Drugs

Optimization of Three Elements of ADC Drugs

Structurally, an ADC consists of monoclonal antibodies (Antibody) that target specific antigens on tumor surfaces, cytotoxic drugs (drugs) that kill tumor cells, and linkers (Conjugate/ linkers) that conjugate cytotoxic drugs to antibodies. ...

ByBiopharma PEG Scientific Inc


Antibody Selection for ADC Drugs

Antibody Selection for ADC Drugs

In theory, molecules that bring effector molecules to the surface of tumor cells can play the role of antibody guidance The choice of antibody for ADC drugs depends on the target of the disease. Targets can be divided into tumor-specific antigens (TSA) and tumor-associated antigens (TAA) according to their expression. ...

ByBOC Sciences


Antibody-Drug Conjugates For The Treatment of Prostate Cancer

Antibody-Drug Conjugates For The Treatment of Prostate Cancer

STEAP1, TROP2, PSMA, CD46, and B7-H3 are currently being looked at as optimal antigens, which have been shown to be targeted by ADCs. 1. ADC For The Treatment of PCa PSMA-based ADCs PSMA (prostate-specific membrane antigen) is a cell membrane protein specifically expressed by prostate cells, and its expression in PCa and metastatic cells is ...

ByHunan Huateng Pharmaceutical Co. Ltd.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT